These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30671448)

  • 1. Personalized Approach to Severe Asthma.
    Heffler E; Canonica GW; Diamant Z; Fonseca J; Malinovschi A
    Biomed Res Int; 2018; 2018():2465172. PubMed ID: 30671448
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine in children with asthma.
    Pijnenburg MW; Szefler S
    Paediatr Respir Rev; 2015 Mar; 16(2):101-7. PubMed ID: 25458797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial research in focus: do trials prepare us to deliver precision medicine in those with severe asthma?
    Brightling CE
    Lancet Respir Med; 2017 Feb; 5(2):92-95. PubMed ID: 28145230
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype-Driven Therapeutics in Severe Asthma.
    Opina MT; Moore WC
    Curr Allergy Asthma Rep; 2017 Feb; 17(2):10. PubMed ID: 28233153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PERSONALIZED TREATMENT OF ASTHMA: THE ISSUE OF ANTI-INTERLEUKIN-5 ANTIBODIES].
    Louis R; Demarche S; Van Hees T; Schleich F
    Rev Med Liege; 2015; 70(5-6):306-9. PubMed ID: 26285457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma: personalized and precision medicine.
    Canonica GW; Ferrando M; Baiardini I; Puggioni F; Racca F; Passalacqua G; Heffler E
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):51-58. PubMed ID: 29189350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances toward precision medicine for asthma.
    Louis R; Bureau F; Desmet CJ
    Biochem Pharmacol; 2020 Sep; 179():114081. PubMed ID: 32511986
    [No Abstract]   [Full Text] [Related]  

  • 9. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
    Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
    Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in pediatric severe asthma: Targeted blockade of type 2 inflammation.
    Larkin AS; Wenzel SE
    Cell Rep Med; 2022 Mar; 3(3):100570. PubMed ID: 35492881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
    De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW
    Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future treatment for asthma.
    Charriot J; Vachier I; Halimi L; Gamez AS; Boissin C; Salama M; Cucu-Jarjour A; Ahmed E; Bourdin A
    Eur Respir Rev; 2016 Mar; 25(139):77-92. PubMed ID: 26929425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics in asthma--the next step toward personalized treatment.
    Darveaux J; Busse WW
    J Allergy Clin Immunol Pract; 2015; 3(2):152-60; quiz 161. PubMed ID: 25754716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dr Elliot F. Ellis: Initiating personalized asthma management in children.
    Szefler SJ
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):3-6. PubMed ID: 29758291
    [No Abstract]   [Full Text] [Related]  

  • 15. Asthma exacerbations during pregnancy: A need for precision medicine.
    Brightling CE
    Respirology; 2020 Jul; 25(7):670-671. PubMed ID: 31840898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Statement of the German Airway League: Pharmacotherapy Register of the Federal Association of the Statutory Health Care Physicians - an Attempt Against the Personalized Medicine?].
    Worth H; Kardos P; Criée CP;
    Pneumologie; 2017 Jan; 71(1):15-16. PubMed ID: 28114709
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolving Concepts of Asthma.
    Gauthier M; Ray A; Wenzel SE
    Am J Respir Crit Care Med; 2015 Sep; 192(6):660-8. PubMed ID: 26161792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma Phenotypes and Endotypes: Implications for Personalised Therapy.
    Dean K; Niven R
    BioDrugs; 2017 Oct; 31(5):393-408. PubMed ID: 28879503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the role of leukotriene-modifying drugs in asthma management: Are their benefits 'losing in translation'?
    Pyasi K; Tufvesson E; Moitra S
    Pulm Pharmacol Ther; 2016 Dec; 41():52-59. PubMed ID: 27651322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?
    Fitzpatrick AM; Moore WC
    J Allergy Clin Immunol Pract; 2017; 5(4):901-908. PubMed ID: 28689840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.